This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Introduction
The lung is an ideal target organ for needle-free immune modulatory or vaccination approaches given its large surface area endowed by a dense network of antigen-presenting cell populations such as dendritic cells (DCs) and macrophages. Drug delivery through the pulmonary route offers several additional advantages over oral or parenteral delivery due to the presence of a dense vasculature, and a lower concentration of drug-metabolizing enzymes in the lung combined with the highly dispersed nature of an aerosol. 1 Free antigen delivered to the respiratory tract, however, usually fails to induce robust protective effects due to rapid degradation. 2 For these reasons, in recent years, engineered nanomaterials have gained increased interest in the field of innovative biomedical applications. In particular, engineered nanoparticle (NP)-based carrier systems (e.g. mainly NPs with all three dimensions below 100nm (ISO/TS, 2008)) have been proposed as novel therapeutic applications to deliver encapsulated or conjugated molecules of interest (e.g. antigens, allergens, drugs, peptides, proteins, genes, etc.) directly to specific cellular targets, such as antigen-presenting cells (APCs), or more specifically DCs. [3] [4] [5] Depending on the degradation rate of the NP-based carrier, such an approach would enable controlled antigen release over time for novel immune-modulatory strategies. 6 To date an increasing number of studies regarding inhalable NP-based carriers is emerging emphasizing the importance of respiratory tract targeting biomedical approaches. For example, recent studies with mice using in particular bio-mimetic nanoparticles demonstrated prolonged persistence, lower inflammatory potential, increased antigen transport to draining lymph nodes, improved specific effector memory T cell responses and significant protection against respiratory challenge infection. 789 In addition, several aerosolized vaccines, such as NP-conjugated to ovalbumin, are being developed and have shown promising first results.
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functionalization with different coatings and charges may alter interactions of NPs with immune
cells. For instance, we recently reported that intra-nasally administered polystyrene particles with a diameter of 20 nm were more frequently captured by DCs, compared to larger 1000 nm particles, and only the smallest particles led to enhanced antigen-specific CD4 + T cell proliferation in lung draining lymph nodes (LDLNs). 13 Despite an increasing body of literature in the area, little is known on how NP surface chemistry and charge govern interaction with resident APC populations in different respiratory tract compartments upon inhalation.
We hypothesized that NP functionalization with different surface charges, i.e. either positive or negative, on gold core-bound polymer will influence uptake, trafficking to DLNs and induction of down-stream immune responses by respiratory tract APC populations. We utilized gold NPs (AuNPs) coated with functionalized positively-charged (NH 3 + ) or negatively-charged (COO -) polyvinyl alcohol (PVA) polymers, as it was shown that such polymers improve the colloidal stability and biocompatibility of NPs. 16 We evaluated the distribution of both NH 2 -PVA and COOH-PVA AuNPs in different respiratory tract compartments after intranasal administration in BALB/c mice, as well as ovalbumin (OVA) uptake, processing and OVA-specific CD4 + T cell proliferation in non-LDLNs and LDLNs by flow cytometry and confocal microscopy.
Methods

Animals
Female BALB/c and DO11.10 TCR transgenic (C.Cg-Tg(DO11.10)10DLo/J) mice were bred specific pathogen free at the Department of Clinical Research (University of Bern, Switzerland) according to the Swiss Federal Veterinary Office guidelines under animal experimentation permission (BE82/12) and used at 8 to 12 weeks of age.
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Intranasal administration of gold nanoparticles (AuNPs) for uptake and trafficking experiments NH 2 -PVA AuNPs and COOH-PVA AuNPs were synthesized and characterized as previously described with a slight modification in the molecular weight of PVA (Mowiol 4-88 Mw=31000, Calbiochem, EMD Bioscience, Inc. La Jolla, CA, USA) to obtain comparable sizes of both NPs. 16, 17 Particle synthesis and intra-nasal instillation is further described in the online supplementary data section.
CFSE-labeled, OVA-specific CD4 + T cell proliferation in naïve animals
Lymph nodes from female DO11.10 mice were collected and CD4 + T cells were isolated using a CD4 negative isolation kit (Dynabeads Untouched Mouse CD4 Cells kit, Invitrogen, Zug, Switzerland). Cells were labeled with carboxyfluorescein succinimidyl ester (CFSE; eBioscience, Vienna, Austria) and 10 7 stained CD4 + T cells per mouse in 200 μl of PBS were intravenously injected. Two days later, AuNPs were administered i.n. as described above, followed by i.n. delivery of 50 μl OVA (Sigma-Aldrich) diluted in PBS (1 mg/ml) 15 min later. Three days later, LDLNs or non-LDLNs (inguinal, axial and gluteal nodes) were collected and labeled for CD4, the DO11.10 TCR (KJ1-26) and CD69 to determine antigen-specific T cell proliferation (CFSE dilution profiles) by flow cytometry. Data was analyzed using the proliferation tool of Flow Jo software (Tree Star, Ashland, OR, USA) and proliferation was expressed as expansion index (EI).
OVA uptake and processing experiments
50 μl of AuNPs (200 μg/ml) or of PBS were administered i.n. in anaesthetized mice, followed 15 min later by 50 μl of OVA-Alexa Fluor 647 (1 mg/ml; Molecular Probes, Lucerne, Switzerland) or by 50 μl of OVA-DQ (1 mg/ml; Molecular Probes) to determine uptake and processing capacity, respectively, by APC populations. Animals were euthanized 2h or 24h after exposure and tissue (trachea, lung parenchyma, DLNs and BAL) was harvested for preparation of single suspension as described above to measure OVA uptake and processing by flow cytometry.
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Gold nanoparticle charge modulates T cell proliferation -Seydoux E et al. Figure 1B ). There was no difference between NH 2 -PVA AuNPs and NH 2 -PVA polymer controls, whereas frequencies of macrophages positive for COOH-PVA AuNPs were significantly higher than those positive for the COOH-PVA polymer alone (p=0.0095). A similar trend was observed in the CD11b + DC subpopulation. Significant higher uptake of NH 2 -PVA polymer occurred compared to COOH-PVA polymer (p=0.011), but differences in uptake did not reach significance between NH 2 -PVA AuNPs and COOH-PVA AuNPs (p=0.09). Particle and polymer uptake frequency by macrophages and DC subpopulations
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in trachea was relatively low (<10%) ( Figure 1B ) with no significant differences seen in macrophages, Figure 1B ) and no differences seen in trafficking between different particle or polymer types. CD8α 
OVA-specific CD4 + T cell proliferation after exposure to OVA and AuNPs
We further examined how NH 2 -PVA or COOH-PVA AuNPs and respective polymers modulated downstream immune responses by measuring antigen-specific CD4 + T cell proliferation in LDLNs.
Following intranasal exposure to OVA/PBS, OVA/NH 2 -PVA AuNPs, OVA/NH 2 -PVA polymers, OVA/COOH-PVA AuNPs or OVA/COOH-PVA polymers, proliferation was significantly increased in LDLNs compared to non-LDLNs (internal negative-control), in which the EI remained around 1 ( Figure   2C ). Significantly increased proliferation was observed in mice exposed to OVA/NH 2 -PVA AuNPs compared to mice receiving OVA/COOH-PVA AuNPs or OVA/PBS. Proliferation in mice exposed to both OVA/NH 2 -PVA polymers and OVA/COOH-PVA polymers was also similar to OVA/PBS exposure
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( Figure 2C ). These results indicate an intrinsic immuno-modulatory effect of intact NH 2 -PVA AuNPs but not the NH 2 -PVA polymer alone.
Expression of co-stimulatory molecules CD40 and CD86 after the administration of AuNPs or polymers
To understand if the observed increased proliferation following exposure to NH 2 -PVA AuNPs was dependent on co-stimulatory molecule expression, we assessed CD40 ( 
OVA uptake and processing after exposure to OVA and AuNPs
We next examined whether NH 2 -PVA AuNPs and COOH-PVA AuNPs induced functional changes in
APCs by measuring antigen uptake and processing in different respiratory tract compartments. OVA coupled to Alexa Fluor-647 and OVA coupled to DQ were used to analyze antigen uptake and antigen processing, respectively 20 . There was an overall trend for increased OVA uptake after 24h exposure compared to 2h exposure ( Figure 5B ), but this reached significance only in BAL macrophages ("COOH", p=0.006) and CD11b + DCs ("NH 2 ", p=0.011; "COOH", p=0.026), in lung parenchyma macrophages ("COOH", p=0.029) and in LDNLs CD11b -DCs ("NH 2 ", p=0.02) ( Figure 5B ). Similarly,
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there was an overall trend for enhanced OVA processing in BAL after 24h compared to the 2h timepoint ( Figure 6 , upper panels). In the lung parenchyma, significantly increased antigen processing occurred in CD11b + DC populations after 24h for both particle types, while in CD11b -DCs higher antigen processing capacity was present early at 2h compared to the 24h late time-point (only significant for "COOH", p=0.034) (Figure 6 , middle panels). Finally, in DC populations, OVA processing in the LDLNs was significantly higher after 24h compared to after 2h ( Figure 6 , lower panels).
Discussion
Colloidal AuNPs are presently used for labeling, drug delivery, heating and sensing in the biomedical field. 21 For drug delivery, AuNPs offer the advantage that they are straightforward to synthesize, with a core size between 1 nm and 150 nm, can be well colloidally stabilized, biocompatible, and may be functionalized with molecules via thiol-gold bonds. 22 
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One salient finding in our study was that the majority of AuNPs, independently of their surface charge, were taken up by macrophages. Recent studies have emphasized the complex role of pulmonary macrophages in inflammatory processes due to their high level of plasticity and their ability to polarize into a plethora of different phenotypes depending on signals present in the microenvironment, 24, 25 which may promote either pro-or anti-inflammatory responses. 26 One of the most important features of respiratory tract macrophages is their distinct phagocytic activity, contributing to tissue homeostasis by the clearance of invading pathogens, debris, as well as apoptotic cells, and preventing inflammatory responses from occurring in order to maintain vital alveolar gas exchange. 27, 28 Moreover, uptake by macrophages is non-specific and NPs are likely to be degraded or inactivated. 22 These findings are in line with a study by Geiser and co-workers that evaluated the distribution of 21 nm AuNPs following aerosolization in BAL and lung parenchyma of wild type mice. 29 They observed that 24h after aerosol inhalation, approximately 80% of AuNPs were found within macrophages, while the remaining AuNPs were attached to or within epithelial cells. In another study utilizing a triple cell co-culture model simulating the alveolar lung epithelium, 15 nm
AuNPs were found to enter all cell types, i.e. epithelial cells, macrophages and DCs; however a quantification of particles per cell type was not performed. 30 In the present study, a differential uptake between NH 2 -PVA and COOH-PVA AuNPs was observed, with amine-functionalized, positively-charged particles preferentially captured by macrophages as compared to carboxylated AuNPs. These results confirm in vitro findings from other groups describing an increased uptake of particles with positive charge (e.g. gold, silver, polystyrene, superparamagnetic iron oxide) compared to negatively-charged particles. 16, [31] [32] [33] [34] Furthermore, a recent in vivo study with mice exposed to hydrogel rod-shaped NPs of different surface charge, showed enhanced uptake by AM, CD11b+ DC and CD103+ DC and enhanced trafficking to the LDLNs compared to anionic NPs. The authors of this study therefore suggested that cationic NPs may serve as potential immunomodulators in the lung. 35 Despite the fact that we have instilled an NP dosage 10 fold lower than the dosage used in the study above, we have detected similar effects of positively charged NPs in the respiratory tract and show
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evidence of a modulated downstream effector T cell response. The effect of positive particle charge may partly be explained by the fact that it favors the adhesion of NPs to the slightly negatively charged cell membrane, although previous studies also showed that the overall charge of both negatively and positively charged NPs in complete medium is similar 34 . Furthermore, the number of dyes per particle was comparable between the two types of NPs (table 1) , therefore differences in ATTO590 fluorescent signal in FACS was due to the number of NPs taken up cells rather than due to a difference in the number of dyes on the particles.
We detected relatively lower frequencies of particle-positive CD11b + and CD11b -DC subpopulations compared to macrophages. Specifically targeting DCs to increase particle uptake will be the great challenge in the development of novel carriers for vaccines in the respiratory tract and may be achieved by coupling ligands (e.g. antibodies) such as anti-DEC205 or anti-DC-SIGN, on the NP surface for binding to DC surface receptors. 36, 37 Similar uptake patterns have already been shown with microand nano-sized polystyrene particles intra-nasally instilled in mice. 13, 38, 39 However, a striking difference in uptake frequency between macrophages and DCs may be explained by the quantity and the location of the cells involved. In particular, located at the luminal side of the alveoli, macrophages represent the first line of defence against deposited pathogens, while DCs, located below the epithelial cells, are present in lower numbers 13, 40 and are not directly exposed to but take up deposited particles by extending their dendrites between the epithelial cells into the alveolar lumen as shown by Thornton and co-workers. 41 In our study, the amount of AuNP internalized as measured by MFI analysis, did not differ between DC subsets and AM, indicating similar endocytic activity in lung APC populations analysed.
Our data indicated that there was no difference in particle uptake between CD11b + and CD11b -DC subpopulations for both types of AuNPs. A previous in vivo study from our group showed that negatively-charged polystyrene NPs of identical diameter (100nm) were captured by both CD11b + and CD11b -DC subpopulations to the same extent. 13 Notably, migratory CD11b -DCs containing 20 nm and 50 nm NPs in LDLNs displayed higher trafficking frequencies compared to migratory CD11b +
A C C E P T E D M A N U S C R I P T
E-cadherin expressed by epithelial cells, CD11b -DCs are known to be located between epithelial cells and to extend their dendrites between the epithelial layer directly into the airway lumen to sample inhaled antigen deposited in the respiratory tract, allowing to efficiently sample inhaled antigen.
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On the other hand, CD11b + DCs are expected to be located in the submucosa of the conducting airways and parenchyma without crossing the airway epithelial barrier. Hence, they only sample antigen that has crossed the basal membrane. Moreover, although no charge-dependent particle uptake frequency was seen among different subpopulations of pulmonary DCs, a trend (p=0.06) for higher uptake of NH 2 -PVA AuNPs was found in CD11b -DC from the lung parenchyma when compared to uptake of COOH-PVA AuNPs in this subpopulation. This finding is in line with the results of a recent study, where similar AuNPs were tested by exposing human monocyte-derived DCs in vitro.
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We detected no charge-dependent differences in frequencies of particle-positive CD11b + and CD11b -DCs in LDLNs. Moreover, we did not observe particle-positive resident CD11b + CD8α + or CD11b -CD8α + DCs after 24h (data not shown), indicating that passive drainage of both NH 2 -PVA and COOH-PVA AuNPs to regional lymph nodes did not take place to any measurable extent. These results are in line with a study by Wikstrom and colleagues, which shows that the majority of inhaled antigens detected in the LDLNs is associated with CD8α -DCs. 45 Also, similar results were found in the study already discussed above, where polystyrene particles of a broad size range from 1000 nm down to 20 nm were mainly found inside CD8α -DCs. 13 Detection of both types of AuNPs in LDLNs was low with less than 2% of DCs being particle-positive. A possible reason for low detection of AuNPs inside DCs of LDLNs may be due to limited sensitivity of the flow cytometry equipment to detect weak signals of ATTO590 or low total amounts of intra-cellular AuNPs. Quantification of NPs with remarkable sensitivity may be achieved by inductively coupled plasma-optical emission spectroscopy (ICP-OES), a method that can quantify intracellular NPs down to a few picograms, and which was used to quantify similar AuNPs upon uptake by human monocyte-derived DCs in vitro as discussed above.
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this technique for in vivo studies would have required extensive cell-sorting which is beyond the scope of this study.
Monitoring T cell activation after AuNP treatment, we made two salient observations: First, a significantly increased proliferation of antigen-specific CD4 + T cells occurred in animals exposed to co-administered OVA/NH 2 -PVA AuNPs as compared to mice that received OVA/PBS or OVA/COOH-PVA AuNPs. Second, NH 2 -PVA functionalised AuNPs, but not the NH 2 -PVA polymer alone induced an enhanced T cell proliferation. From these two findings three important conclusions may be drawn:
(1) DC-dependent trafficking of positively-charged NH 2 -PVA AuNPs and antigen to LDLNs was sufficient to induce CD4 + T cell stimulation, (2) NP surface charge determines downstream T cell activation, and (3) the "intact" NP core-polymer hybrid is essential to trigger a downstream immune responses. Our second conclusion harmonizes well with the current literature where, for example, a recent study by Choi and co-workers demonstrated the importance of NP surface charge affecting individual trafficking patterns following instillation into the lungs of rats. 46 Altered particle trafficking to the LDLNs due to particle surface charge may therefore strongly affect downstream immune responses. Supporting our third conclusion, another recent study investigating pro-inflammatory effects of Iron (Fe)-and Au-NP embedded in a poly(methacrylic acid) (PMA) and particle shells alone, also demonstrated altered pro-inflammatory response when coated NPs were compared to shells alone or when different cores (with the same PMA coating) were compared together. 47 To our knowledge the current study is the first description in the field demonstrating that surface charge of NPs alters in vivo CD4 + T cell proliferation and that this effect is not restricted to the polymer coating, but requires "intact" NPs with a core-bound polymer shell.
To explain the altered T cell activation with NH 2 -PVA modified AuNPs we investigated the effect of
AuNPs on activation and function of respiratory tract DCs. We measured the expression of the costimulatory surface molecules CD40 and CD86 as markers for DC activation following uptake of
AuNPs. The baseline frequency of expression of both CD40 and CD86 was generally increased in both DC-and macrophages that contained particles, independently of the surface charge, except in BAL
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where COOH-PVA AuNPs and polymers induced a higher expression of CD40 and CD86 compared to their NH 2 equivalents. A possible explanation for the lower frequencies of activated DCs containing NH 2 -PVA AuNPs in the BAL may be an increased migration of activated DCs from the alveolar space to LDLNs, where these cells trigger an increased CD4 + T stimulation. In line with the current study, our recent investigation analyzing size-dependent trafficking of different sized polystyrene nanoparticles in the respiratory tract of BALB/c mice also revealed the presence of activated macrophages and DCs (CD40 ± , CD86 ± ) following uptake, independent of particle size. 13 Also, we observed that the potential of DCs to take up and process OVA antigens was also not altered by the exposure to both types of AuNPs, therefore increased CD4 + T cell proliferation cannot be explained by an alteration of DC activation. Furthermore, we measured levels of early apoptosis and necrosis by means of Annexin-V and PI staining in DC and AM populations following exposure to PBS and both types of AuNPs or polymers. Our results showed no significantly increased apoptosis or necrosis any treatment group compared to PBS controls ( Figure E3 ), indicating that the observed effects of NH2-PVA AuNPs are not explained toxicity-related inflammatory responses in the different lung compartments. Other reasons for increased proliferation could be explored, such as altered T cell cytokine secretion profiles 48 
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Expression of CD40 was determined 24h after administration in particle-positive ("AuNP+") and particle-negative ("AuNP-") cell populations within the same animal and compared to PBS-exposed animals ("PBS"). Expression of CD86 was determined 24h after administration in particle-positive ("AuNP+") and particle-negative ("AuNP-") cell populations within the same animal and was compared to PBS- 
